Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Exelixis

Tracked across 2 events · 12 articles · First seen Jul 31, 2026 · Last active Aug 12, 2026

Sentiment
-30
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 -40
Regulatory
Impact: Exelixis is the subject of the investigation. Its shares fell after reporting Q2 revenue below consensus and lowering full-year guidance, and it now faces potential securities litigation.
Aug 10, 2026 · 6 articles
4 -20
Regulatory
Impact: Exelixis markets CABOMETYX, the reference product to which OMCAZIO is bioequivalent. The approval of a lower-dose alternative could increase competition and pressure its market share.
Jul 31, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Exelixis live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.